This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Scott, J. Search for Related Content PubMed PubMed Citation Articles by Scott, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Lipoproteins, Inflammation and Atherosclerosis

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:528.)
© 2003 American Heart Association, Inc.

ATVB In Focus

ATVB In Focus

Lipoproteins, Inflammation, and Atherosclerosis

James Scott

From the Department of Medicine Administration, Hammersmith Hospital, London, UK.

Correspondence to Dr James Scott, Department of Medicine Administration, Hammersmith Hospital, Du Cane Rd, London, W12 ONN UK. E-mail jscott@rpms.ac.uk

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The brief review by Pennacchio and Rubin¹ in this issue of Arteriosclerosis, Thrombosis, and Vascular Biology is the first of the Series, which highlights how innovative technology and research is breathing new life into the role of lipoproteins in health and disease. Lipoproteins have been around for a long time. Primitive lipoproteins found in worms (Caenorhabditis elegans) and flies (Drosophila melanogaster), the so-called lipovitellins, are closely related mammalian lipoproteins. Lipoprotein research has also been with us for quite a while. In the early 1950s, the pioneering work of the Lawrence Berkeley National Laboratory used ultracentrifugation to fractionate and classify the plasma lipoproteins. In the ensuing years, much has been learned about the role of lipoproteins in health and disease. Oxidized LDL is established as the argent provocateur of the arteriosclerosis. HDL is atheroprotective through its role in reverse cholesterol transport and its anti-inflammatory properties. However, with the advent and fabulous success of the statin drugs, a view emerged that lipoprotein research had reached its sunset. If there is any lingering doubt that this not the case, I am convinced this series will change this view.

See page 529

It seems highly appropriate that the first article in this new series of reviews should come from the Lawrence Berkeley National Laboratory. In their review, Pennacchio and Rubin¹ show that even today the lipoprotein system is full of surprises. Nobody would have guessed that the sequence of the human genome would reveal an overlooked apolipoprotein in the apoAI/CIII/AIV . . . [Full Text of this Article]